A new analysis from The New York Times, along with German outlets NDR and WDR, took a closer look at the administration’s new drug pricing platform, TrumpRx. What they found is that while some prices have come down, Americans are still paying significantly more than patients in other wealthy countries,
Politics
·
Admin touts TrumpRX success: it’s a quick fix, not real progress!
CN
CitrixNews Staff
Originally reported by The Hill
Related Articles
Politics
When to Expect Results in Maine, Nevada and Beyond
Four states have primaries on Tuesday. Election officials predict most results will come in late in the evening, though ...
CitrixNews Staff
·
46 minutes ago
Politics
Meta accuses Israeli spyware firm of again targeting WhatsApp users
Meta accused an Israeli spyware firm on Monday of violating a court order restricting phishing attempts on WhatsApp, a s...
CitrixNews Staff
·
50 minutes ago
Politics
Watchdog Group Skeptical of Vows to End Trump Administration’s $1.8 Billion Fund
Two sets of lawyers noted that while senior department officials said the fund would not move forward, they declined to ...
CitrixNews Staff
·
1 hour ago
Politics
DOJ finds EEOC guidelines on workplace discrimination unconstitutional
The Justice Department on Tuesday found the Equal Employment Opportunity Commission’s (EEOC) hiring guidelines unconstit...
CitrixNews Staff
·
1 hour ago